Conclusions
MDD
In summary, the preliminary findings from this pilot study suggest that 8-week adjunctive treatment with a multistrain probiotic is acceptable and tolerable for adults with MDD. The estimated effect sizes on key clinical outcomes are promising and encourage further investigation in a definitive efficacy trial.